Effect of 3-Beta Hydroxysteroid Dehydrogenase on Serum Testosterone Level in Obese Women With Polycystic Ovary Syndrome
DOI:
https://doi.org/10.36329/jkcm/2025/v4.i2.16065Keywords:
3BHSD, PCOS, LH, FSH, HyperandrogenismAbstract
Background: Polycystic Ovary Syndrome is the most prevalent endocrinological condition affecting women in their reproductive years, which is typified by elevated (LH:FSH) ratios, hyperandrogenism, and persistent ovulatory failure. Insulin resistance and obesity have been connected to PCOS. That being said, a significant number of thin women are now receiving PCOS diagnoses. (3βHSD2) deficiency is a rare kind of congenital adrenal hyperplasia (CAH) that causes the gonads and adrenals to produce less steroid hormones. A large number of follicles larger than 8 mm make up pcos. When the follicles' sacs are still developing, the eggs develop. Ovulation does not occur in PCOS due to these sacs' incapacity to release an egg.
Material and methods: The study included approximately 90 women, ages 18 to 40 year, who were split into three groups of 30 obese women ,30 non-obese women who have PCO, the third group comprises of 30 women who look to be in good health and serves as the control group. Women who smoke, hypertension, or who use hormonal drugs, pregnancy, DM,thyroid disease were excluded from this groups.
Results: A considerable increase in serum level ofTestosterone, LH, LH:FSH and Prolactin levels, while the decline of 3BHSD(p< 0.0001) and FSH(p< 0.002). in serum level patients value in PCO women than the control group .The ROC analysis of 3BHSD for distinguishing patient from controls demonstrated an AUC of 0.866, indicating poordiagnostic potential.
Conclusion: the present study focusing on less frequently identified enzyme and hormones that might be interrelate with the pathogenesis of PCOS. For 3BHSD,our results stated that poor diagnostic value in the diagnosis ofpcos in patients.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Nabaa Faaz, Prof., Prof.

This work is licensed under a Creative Commons Attribution 4.0 International License.
which allows users to copy, create extracts, abstracts, and new works from the Article, alter and revise the Article, and make commercial use of the Article (including reuse and/or resale of the Article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made and the licensor is not represented as endorsing the use made of the work.

